Cleared Traditional

K231222 - 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) (FDA 510(k) Clearance)

Oct 2023
Decision
185d
Days
Class 2
Risk

K231222 is an FDA 510(k) clearance for the 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2). This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Topcon Corporation (Itabashi-Ku, JP). The FDA issued a Cleared decision on October 30, 2023, 185 days after receiving the submission on April 28, 2023.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K231222 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 28, 2023
Decision Date October 30, 2023
Days to Decision 185 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO - Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.